P1207: SERIAL SINGLE-CELL PROFILING OF MANTLE CELL LYMPHOMA REVEALS FUNCTIONAL AND MOLECULAR CORRELATES OF RESISTANCE TO BTK INHIBITOR-INCLUSIVE TRIPLET THERAPY

• Lydie Debaize,
• Ye Zhang,
• Michelle Ramseier,
• Mingzeng Zhang,
• Adam Langenbucher,
• Peter S. Winter,
• Ran Xu,
• Nezha Senhaji,
• Robert A Redd,
• Martin J. Aryee,
• Paul H. Branch,
• Austin I. Kim,
• David M. Weinstock,
• Alex Shalek,
• Scott R. Manalis,
• Mark A. Murakami

Affiliations

Lydie Debaize

1 Dana-Farber Cancer Institute, Department of Medical Oncology, Boston, United States

Ye Zhang

3 Koch Institute For Integrative Cancer Research at MIT, Cambridge, United States

Michelle Ramseier

3 Koch Institute For Integrative Cancer Research at MIT, Cambridge, United States

Mingzeng Zhang

1 Dana-Farber Cancer Institute, Department of Medical Oncology, Boston, United States

Adam Langenbucher

3 Koch Institute For Integrative Cancer Research at MIT, Cambridge, United States

Peter S. Winter

3 Koch Institute For Integrative Cancer Research at MIT, Cambridge, United States

Ran Xu

1 Dana-Farber Cancer Institute, Department of Medical Oncology, Boston, United States

Nezha Senhaji

1 Dana-Farber Cancer Institute, Department of Medical Oncology, Boston, United States

Robert A Redd

2 Harvard Medical School, Boston, United States

Martin J. Aryee

2 Harvard Medical School, Boston, United States

Paul H. Branch

1 Dana-Farber Cancer Institute, Department of Medical Oncology, Boston, United States

Austin I. Kim

1 Dana-Farber Cancer Institute, Department of Medical Oncology, Boston, United States

David M. Weinstock

1 Dana-Farber Cancer Institute, Department of Medical Oncology, Boston, United States

Alex Shalek

3 Koch Institute For Integrative Cancer Research at MIT, Cambridge, United States

Scott R. Manalis

3 Koch Institute For Integrative Cancer Research at MIT, Cambridge, United States

Mark A. Murakami

1 Dana-Farber Cancer Institute, Department of Medical Oncology, Boston, United States